According to the World Stroke Organization, one out of every four adults over the age of 25 years old worldwide will have a stroke in their lifetime.

Big Pharma has some obvious advantages, but drug startups are wasting no time tapping AI to streamline drug R&D processes, thus shortening turnaround time across the value chain.

Protein “folding” is one of the cornerstones of biological life, and AI is helping scientists crack the code of how it works.

While scheduling manually has obviously been the rule for years, AI is beginning to help healthcare organizations iron out the usual bottlenecks, thus taking pressure off medical staff.

According to the researchers, the new technology provides key advantages over traditional sensors, including high conductivity, flexibility and stretchability, and it could provide a higher level of intelligence for artificial hands.

Along with helping doctors at the point of care, precision dosing is helping pharmaceutical companies hone their clinical trials in order to maximize the effectiveness of new therapies.

Offering personalized answers for new patients, the new app seeks to empower cancer patients and their families with information to steer their cancer journey.

According to the team, the new insights into aging could be used as a diagnostic tool for identifying those at risk for both noncommunicable and infectious diseases.

Among other things, the team found that inpatient mortality decreased over time from March and April 2020 to September and October, and treatment patterns changed, as well.